Search
Go
Displaying Results for "cadila healthcare"
  • Cadila Healthcare Limited - Press Release

    Cadila Healthcare Limited - Press Release cadila Healthcare Limited - Press Release

    capital market | Mumbai 00:00 IST | October 16, 2017

  • Cadila Healthcare recovers after getting USFDA nod for drug

    Cadila Healthcare recovers after getting USFDA nod for drug cadila Healthcare gained 1.36% to Rs 498.05 at 14:#0 IST on BSE after the company said that it received final approval from the US drug regulator to market Desvenlafaxine Extended-Release Tablets, 50 mg and 100 mg.

    capital market | Mumbai 14:58 IST | October 12, 2017

  • Cadila Healthcare Limited - Press Release

    Cadila Healthcare Limited - Press Release cadila Healthcare Limited - Press Release

    capital market | Mumbai 00:00 IST | October 12, 2017

  • Cadila Healthcare to discuss results

    Cadila Healthcare to discuss results on 14 November 2017

    capital market | Mumbai 17:52 IST | October 11, 2017

  • Cadila Healthcare to discuss results

    Cadila Healthcare to discuss results cadila Healthcare to discuss results

    capital market | Mumbai 00:00 IST | October 11, 2017

  • Cadila Healthcare advances after receiving USFDA nod for drugs

    Cadila Healthcare advances after receiving USFDA nod for drugs cadila Healthcare rose 1.36% to Rs 507.30 at 10:10 IST on BSE after the company said that it has received the final approval from the United States Food & Drug Administration to market two drugs.

    capital market | Mumbai 10:16 IST | October 09, 2017

  • Cadila receives USFDA approval for Amitriptyline Hydrochloride tablets

    In a BSE filing, Cadila Healthcare informed that Zydus Cadila has received the final approval from the USFDA to market Amitriptyline Hydrochloride Tablets...

    India Infoline News Service | Mumbai 09:42 IST | October 09, 2017

  • Cadila Healthcare Limited - Press Release

    Cadila Healthcare Limited - Press Release cadila Healthcare Limited - Press Release

    capital market | Mumbai 00:00 IST | October 09, 2017

  • Top open interest gainers on Thursday

    Open interest and share prices of BEML, Indo Count Industries and Cadila Healthcare have witnessed long build up positions during Thursdays trading session....

    India Infoline News Service | Mumbai 14:38 IST | October 05, 2017

  • Cadila Healthcare receives USFDA nod for Fesoterodine Fumarate tablet

    The share of Cadila Healthcare advanced by over 1% during Thursdays trading session after the company informed that it has received the final approval from the USFDA to market Fesoterodine Fumarate extended-release tablets, 4 mg and 8 mg....

    India Infoline News Service | Mumbai 12:38 IST | October 05, 2017

  • Cadila Healthcare Limited - Press Release

    Cadila Healthcare Limited - Press Release cadila Healthcare Limited - Press Release

    capital market | Mumbai 00:00 IST | October 05, 2017

  • Cadila Healthcare Limited - Press Release

    Cadila Healthcare Limited - Press Release cadila Healthcare Limited - Press Release

    capital market | Mumbai 00:00 IST | October 04, 2017

  • Cadila Healthcare Limited - Press Release

    Cadila Healthcare Limited - Press Release cadila Healthcare Limited - Press Release

    capital market | Mumbai 00:00 IST | October 03, 2017

  • Zydus gets USFDA approval for Doxycycline tablets

    The stock of Cadila Healthcare shot up by over 2% during Fridays trade as Zydus received the final approval from the USFDA for Doxycycline Tablets USP....

    India Infoline News Service | Mumbai 12:57 IST | September 29, 2017

  • Cadila Healthcare Limited - Press Release

    Cadila Healthcare Limited - Press Release cadila Healthcare Limited - Press Release

    capital market | Mumbai 00:00 IST | September 29, 2017

  • Cadila Healthcare Limited - Press Release

    Cadila Healthcare Limited - Press Release cadila Healthcare Limited - Press Release

    capital market | Mumbai 00:00 IST | September 27, 2017

  • Cadila Healthcare extends gains after receiving USFDA nod for drug

    Cadila Healthcare extends gains after receiving USFDA nod for drug cadila Healthcare rose 0.38% to Rs 505.30 at 10:05 IST on BSE, with the stock extending previous sessions gains triggered by the company receiving final approval from the US drug regulator to market Itraconazole Capsules 100 mg.

    capital market | Mumbai 10:09 IST | September 22, 2017

  • Zydus receives final approval from USFDA for Itraconazole Capsules

    Zydus Cadila Healthcare announced on Thursday that the company received the final approval for Itraconazole Capsules from the USFDA, surging the companys stock on the bourses....

    India Infoline News Service | Mumbai 15:44 IST | September 21, 2017

  • Cadila Healthcare Limited - Press Release

    Cadila Healthcare Limited - Press Release cadila Healthcare Limited - Press Release

    capital market | Mumbai 00:00 IST | September 21, 2017